GRIP Molecular Technologies, Inc.
GRIP Molecular is a Minnesota-based biotech company dedicated to developing next-generation medical diagnostics that enable lab-quality results in minutes for homes and clinics. Their innovative nucleic acid amplification process significantly increases diagnostic accuracy, sensitivity, and specificity, making rapid testing easy, sample-agnostic, and cost-effective. The company's mission is to provide lab-grade diagnostic results at the point-of-need, transforming healthcare with technology that is accessible, reliable, and fast.
Industries
Nr. of Employees
small (1-50)
GRIP Molecular Technologies, Inc.
Products
Point-of-need nucleic acid-enhanced diagnostic platform (in development)
A diagnostic platform that combines non-thermal nucleic acid amplification with enhanced lateral flow and a solid-state biosensor to deliver laboratory-grade sensitivity and specificity at the point-of-need, with wireless smartphone readout.
Point-of-need nucleic acid-enhanced diagnostic platform (in development)
A diagnostic platform that combines non-thermal nucleic acid amplification with enhanced lateral flow and a solid-state biosensor to deliver laboratory-grade sensitivity and specificity at the point-of-need, with wireless smartphone readout.
Services
Collaborative development and partnerships
Partnerships and collaboration for development, testing, and commercialization of diagnostic technologies, including grant-supported projects.
Collaborative development and partnerships
Partnerships and collaboration for development, testing, and commercialization of diagnostic technologies, including grant-supported projects.
Expertise Areas
- Point-of-care diagnostics
- Molecular diagnostics
- Biosensor development
- Non-thermal nucleic acid amplification
Key Technologies
- Non-thermal nucleic acid amplification (NTA)
- Lateral flow assay enhancement
- Graphene-based solid-state biosensors
- Dielectrophoresis-enhanced target capture